Winton Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,800	Closed	-$3.1M	–	917
2025 Q3	$3.1M	Buy	6,800 +3,267	+92%	+$1.33M	0.12%	229
2025 Q2	$1.15M	Buy	+3,533	New	+$978K	0.06%	384
2024 Q2	–	Sell	-1,471	Closed	-$220K	–	569
2024 Q1	$220K	Buy	+1,471	New	+$245K	0.02%	550
2023 Q2	–	Sell	-3,425	Closed	-$686K	–	769
2023 Q1	$686K	Buy	+3,425	New	+$720K	0.04%	572
2022 Q2	–	Sell	-3,046	Closed	-$497K	–	936
2022 Q1	$497K	Buy	+3,046	New	+$464K	0.03%	683
2021 Q4	–	Sell	-2,911	Closed	-$550K	–	1004
2021 Q3	$550K	Buy	+2,911	New	+$546K	0.03%	815
2020 Q4	–	Sell	-8,298	Closed	-$1.21M	–	1311
2020 Q3	$1.21M	Sell	8,298 -26,472	-76%	-$3.76M	0.04%	734
2020 Q2	$5.15M	Buy	34,770 +25,785	+287%	+$3.48M	0.13%	200
2020 Q1	$978K	Buy	+8,985	New	+$1.04M	0.03%	810
2017 Q4	–	Sell	-90,504	Closed	-$10.6M	–	662
2017 Q3	$10.6M	Buy	+90,504	New	+$7.73M	0.34%	76